₹0.00
Recently, National drug pricing regulator NPPA has fixed the retail prices of 36 formulations, including those used for treatment of cancer, diabetes, infections, asthma, seizures, inflammation and pain, among others. As per data available with NPPA, the MRP for 105 brands will be reduced up to 85% entailing minimum saving of Rs 105 crore to ..
Kerala has become the first State to set up a Price Monitoring and Research Unit (PMRU) to track violation of prices of essential drugs and medical devices under the Drugs Price Control Order (DPCO). The move comes more than 5 years after the National Pharmaceutical Pricing Authority (NPPA) proposed such a system for the States ..
In a landmark ruling, the Delhi High Court has ordered a ban on the sale of medicines online by e-pharmacists across India and has directed the Delhi government and the Centre to put the order into effect immediately. The order was passed by a division bench of Chief Justice Rajendra Menon and Justice V Kameswar ..
The Union Ministry of Health and Family Welfare has recently released the draft rules on sale of drugs by e-pharmacies with an aim to regulate online sale of medicines across the country. It aims at providing patients accessibility to genuine drugs from authentic online portals. The draft rules on “sale of drugs by e-pharmacy” stated ..
Delhi High Court has given a major relief to the pharmaceutical sector by lifting a ban on more than 300 fixed dose combination drugs. 344 drugs had been banned due to potential health risks and an apparent lack of therapeutic justification. Fixed Dose Combination Drugs is a mixture of more than two drugs in a ..